XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Asian currencies eke out gains on muted dollar



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>EMERGING MARKETS-Asian currencies eke out gains on muted dollar</title></head><body>

.

Thailand baht gains most among Asian FX

RBI holds interest rates at 6.50%

Shanghai stocks reverse Tuesday's gains

By Sneha Kumar and Archishma Iyer

Oct 9 (Reuters) -Most emerging Asian currencies registered minor gains against a broadly muted dollar on Wednesday, as investors sought data to assess the Federal Reserve's rate cut path.

Thailand's baht THB=TH appreciated as much as 0.8% before pulling back gains to 0.3%. It is the second-best performing currency in the region this year, after the Malaysian ringgit, with a near 2% jump.

The currency of Southeast Asia's second-largest economy has been buoyed recently by U.S. interest rate cut bets, stabilising politics and economic growth.

"For the baht, there could be some USD-selling interest from market players especially exporters as they have been waiting for the baht to weaken a bit," said Poon Panichpibool, a markets strategist at Krung Thai Bank.

At 0744 GMT, the dollar index inched higher to 102.64.

The Indonesian rupiah IDR= was up 0.2%, while the Malaysian ringgit MYR= rose marginally.

The Philippines peso PHP= was a notable outlier, falling about 0.3% to its lowest since mid-August.

"Until the sentiment-driven market aligns with the Fed’s underlying outlook for lower inflation and interest rates, currencies are likely to lack direction from markets over-reacting to better- or worse-than-expected data," analysts from DBS wrote.

Global investors are now awaiting a key inflation print from the U.S., as well as minutes from the Fed's latest monetary policy meeting later in the day, for a better sense of where interest rates could be headed.

Falling U.S. rates boost the attractiveness of riskier emerging market assets, particularly in Southeast Asia.

In India, stocks .NSEI rose as much as 0.9% after the Reserve Bank of India changed its policy stance to neutral and opened the door to cuts as early as December, while the rupee INR=IN remained flat.

The central bank maintained its key interest rate steady at 6.50% as expected.

Elsewhere, the Bank of Korea is expected to move with a 25-basis points cut later this week.

Among other Asian equities, Taipei .TWII rose as much as 1.2% to its highest level in nearly two weeks, before ending 0.2% higher.

Shares in Singapore .STI rose 0.5%, while Bangkok .SETI and Kuala Lumpur .KLSE inched up 0.2% each.

Meanwhile, equities in Shanghai .SSEC snapped a 10-day winning streak, tumbling 6.6% and erasing all gains from the previous session.

The index had risen as much as 10.1% on Tuesday on anticipation of more strong stimulus measures from Beijing which failed to materialise.

Markets in South Korea were closed for a public holiday.


HIGHLIGHTS:

** Thailand approves $400 mln investment by Continental AG to expand tyre facility

** India, S. Korea bonds to join FTSE Russell government indexes in 2025

** China's finance ministry to detail fiscal policy on Saturday


Asian currencies and stocks at 0744 GMT

COUNTRY

FX RIC

FX DAILY %

FX YTD %

INDEX

STOCKS DAILY %

STOCKS YTD %

Japan

JPY=

-0.20

-5.00

.N225

0.89

17.37

China

CNY=CFXS

+0.02

+0.49

.SSEC

-6.62

9.54

India

INR=IN

+0.01

-0.89

.NSEI

0.53

15.72

Indonesia

IDR=

+0.16

-1.41

.JKSE

-0.48

3.41

Malaysia

MYR=

0.05

+7.17

.KLSE

0.19

12.66

Philippines

PHP=

-0.30

-2.83

.PSI

-1.50

15.11

S.Korea

KRW=KFTC

-

-4.31

.KS11

-

-2.29

Singapore

SGD=

-0.03

+1.15

.STI

0.47

10.87

Taiwan

TWD=TP

0.00

-4.61

.TWII

0.21

26.37

Thailand

THB=TH

+0.25

+2.03

.SETI

0.17

2.79


Graphic: World FX rates https://tmsnrt.rs/2RBWI5E

Asian stock markets https://tmsnrt.rs/2zpUAr4


Reportingby Sneha Kumar and Archishma Iyer in Bengaluru; Editing by Kim Coghill and Varun H K

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.